Latest news with #SemlerScientific
Yahoo
3 days ago
- Business
- Yahoo
Maxim Group Maintains a Buy Rating on Semler Scientific (SMLR), Sets a $95 PT
Semler Scientific, Inc. (NASDAQ:SMLR) is one of the . Analyst Matthew Galinko of Maxim Group maintained a Buy rating on Semler Scientific, Inc. (NASDAQ:SMLR) on August 6, retaining the price target of $95.00. A doctor in focus surrounded by colleagues in a hospital setting. The analyst told investors that Semler Scientific, Inc. (NASDAQ:SMLR) has exhibited a strong commitment to the accumulation of Bitcoin, with a goal to hold 10,000 BTC by the end of 2025 and considerably more in the following years. He added that Semler Scientific, Inc.'s (NASDAQ:SMLR) ability to raise considerable funds through share issuance further supports this accumulation strategy, suggesting a strong financial strategy. Galinko further stated that Semler Scientific, Inc. (NASDAQ:SMLR) is also expanding its medical technology offerings, especially with the formation of CardioVanta, a subsidiary focused on cardiovascular market opportunities. The expected approval of new diagnostic devices may expand the company's market reach, enhancing its revenue potential. Semler Scientific, Inc. (NASDAQ:SMLR) provides technology and software solutions to improve the clinical effectiveness of healthcare providers. The company's multi-test service platform, WellChec, conducts a comprehensive evaluation of patients for chronic disease, including strokes and heart attacks, through the use of its QuantaFlo product as well as other tests. While we acknowledge the potential of SMLR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
06-08-2025
- Business
- Yahoo
Bitcoin Treasury Firm Semler Scientific Still Has 3X Upside: Benchmark
Semler Scientific (SMLR) is trading just above the market value of its bitcoin holdings, with a market NAV (mNAV) of 1.04, highlighting what broker Benchmark calls a significant valuation disconnect. Markets, argued analyst Mark Palmer following the company's second quarter earnings yesterday, are giving "virtually no credit for [Semler's] ample room to use 'intelligent leverage' to add to its bitcoin holdings." Reiterating his buy rating and $101 price target — or nearly triple the current price of $35 — Palmer said there's much "upside optionality" not priced into the stock. Unlike other bitcoin treasury firms that lean on aggressive equity issuance, Semler is embracing a 'slow money' approach, wrote Palmer. Newly appointed Director of Bitcoin Strategy Joe Burnett laid out a plan to scale bitcoin holdings through a mix of operating cash flow, low-cost convertible debt, and selective at-the-money (ATM) issuances, all aimed at preserving shareholder value and avoiding dilution. The company holds $100M in 4.25% convertible notes due 2030 and, according to management, has significant headroom to issue long-term, bitcoin-backed debt to amplify equity upside, the report noted. As of July 31, Semler held 5,021 bitcoin with a $475.8 million cost basis and a market value of $586.2 million, reflecting a $110.4 million unrealized gain and a 31.3% year-to-date BTC yield. Management remains confident in reaching its target of 10,000 BTC by year-end 2025, and long-term goals of 42,000 BTC by 2026 and 105,000 by 2027. Benchmark's $101 target is based on a sum-of-the-parts analysis incorporating the expected future value of Semler's bitcoin treasury alongside its healthcare operations, including the emerging CardioVanta unit. The stock, trading near its bitcoin net asset value (NAV), reflects little premium for its strategic flexibility, a gap Benchmark believes will close as the company executes on its capital strategy.
Associated Press
30-07-2025
- Business
- Associated Press
Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation
NEW YORK, July 30, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public. So What: If you purchased Semler Scientific securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. What to do next: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. What is this about: After trading hours on February 28, 2025, Semler Scientific filed with the SEC its 2024 annual report on Form 10-K. The annual report disclosed that on February 11, 2025, Semler Scientific 'began initial settlement discussions with DOJ [(the United States Department of Justice)], but ceased initial discussions on that date. Accordingly, there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages. [Semler Scientific] does not believe the amount of loss can be reasonably estimated.' On this news, Semler Scientific's stock fell over 9% on the next trading day. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] View original content to download multimedia: SOURCE THE ROSEN LAW FIRM, P. A.
Yahoo
09-07-2025
- Business
- Yahoo
Semler Scientific Gets Buy Rating From Benchmark, $101 Price Target on Bitcoin Treasury Pivot
Benchmark's Mark Palmer initiated coverage of Semler Scientific (SMLR) with a buy rating and a $101 price target, citing the company's dramatic pivot from medical diagnostics to bitcoin (BTC) accumulation as a key value driver. Semler, which spent over 15 years focused on chronic disease detection, adopted bitcoin as its primary treasury reserve asset in May last year. The move made it only the second U.S.-listed firm, after Michael Saylor's Strategy (MSTR), to adopt bitcoin as a treasury reserve asset. Since then, the company has acquired roughly 4,636 BTC for $430 million, with an average cost basis of $92,753 per bitcoin, the report said. Palmer noted that the stock rallied 178% in the six and a half months following its Bitcoin Standard announcement, peaking at $81.56 in December 2024. However, the analyst argued that Semler still trades at a steep discount compared to bitcoin treasury peers. Its multiple of net asset value (mNAV) sits at 1.25, compared to 4.29 for Japan-based Metaplanet (3350) and 6.45 for France's Blockchain Group (ALTBG), the analyst noted. Benchmark believes this gap could close. Management recently appointed Joe Burnett as Director of Bitcoin Strategy and outlined bold BTC accumulation targets: 10,000 BTC by end of 2025, 42,000 by end of 2026, and 105,000 by end of 2027. The report notes that resolving legal and regulatory headwinds from Semler's legacy healthcare business, including a Department of Justice (DOJ) investigation and Medicare reimbursement uncertainties, could help lift its valuation further. Benchmark's $101 price target is based on a sum-of-the-parts valuation that assumes bitcoin will hit $225,000 by year-end 2026.
Associated Press
03-07-2025
- Business
- Associated Press
ROSEN, LEADING INVESTOR COUNSEL, Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation
New York, New York--(Newsfile Corp. - July 3, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Semler Scientific securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. WHAT IS THIS ABOUT: After trading hours on February 28, 2025, Semler Scientific filed with the SEC its 2024 annual report on Form 10-K. The annual report disclosed that on February 11, 2025, Semler Scientific 'began initial settlement discussions with DOJ [(the United States Department of Justice)], but ceased initial discussions on that date. Accordingly, there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages. [Semler Scientific] does not believe the amount of loss can be reasonably estimated.' On this news, Semler Scientific's stock fell over 9% on the next trading day. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: , on Twitter: or on Facebook: . Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit
